# Upstream Bio, Inc.: Form 8-K, filed Mar 12, 2025

- Company: [Upstream Bio, Inc.](/companies/upb.md) (CIK 2022626)
- Form: 8-K
- Filed: 2025-03-12
- Accepted by EDGAR: Mar 12, 2025, 07:05 ET
- Period: 2025-03-12
- Accession: 0000950170-25-037619
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/2022626/000095017025037619/upb-20250312.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2022626/000095017025037619/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2022626/000095017025037619/upb-20250312.htm

Filed Mar 12, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-037619. Last ingested by Listed: Oct 29, 2026, 16:14 ET. No prices; not investment advice.